P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Background: Purine receptors play roles in peripheral and central sensitization and are associated with migraine headache. We investigated the possibility that ATP plays a permissive role in the activation of AMPA receptors thus inducing Glu release from nerve terminals isolated from the rat trigeminal caudal nucleus (TCN). Methods: Nerve endings isolated from the rat TCN were loaded with [3 H]D-aspartic acid ([3 H]D-ASP), layered into thermostated superfusion chambers, and perfused continuously with physiological medium, alone or with various test drugs. Radioactivity was measured to assess [3 H]D-ASP release under different experimental conditions. Results: Synaptosomal [3 H]D-ASP spontaneous release was stimulated by ATP and to an even greater extent by the ATP analogue benzoylbenzoylATP (BzATP). The stimulation of [3 H]D-ASP basal release by the purinergic agonists was prevented by the selective P2X7 receptor antagonist A438079. AMPA had no effect on basal [3 H]D-ASP release, but the release observed when synaptosomes were exposed to AMPA plus a purinoceptor agonist exceeded that observed with ATP or BzATP alone. The selective AMPA receptor antagonist NBQX blocked this “excess” release. Co-exposure to AMPA and BzATP, each at a concentration with no release-stimulating effects, evoked a significant increase in [3 H]D-ASP basal release, which was prevented by exposure to a selective AMPA antagonist. Conclusions: P2X7 receptors expressed on glutamatergic nerve terminals in the rat TCN can mediate Glu release directly and indirectly by facilitating the activation of presynaptic AMPA receptors. The high level of glial ATP that occurs during chronic pain states can promote widespread release of Glu as well as can increase the function of AMPA receptors. In this manner, ATP contributes to the AMPA receptor activation involved in the onset and maintenance of the central sensitization associated with chronic pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Effects of purinergic receptor agonists on basal and 12 mM [K+]e-evoked [3H]D-ASP release from rat TCN synaptosomes. a Effects of ATP on basal and [K+]e-evoked release of [3H]D-ASP. Synaptosomes prelabeled with [3H]D-ASP were superfused with standard medium at a flow rate of 0.6 ml/min. At the beginning of min 38 (arrow), the medium was replaced with standard medium containing ATP (1 mM) or depolarizing medium (12 mM [K+]e) plus ATP (1 mM) (arrow) and perfusion continued for 4 min (i.e., minute 38 through min 41). Radioactivity in each fraction has been expressed as a percentage of the total radioactivity content present in the tissue at the onset of the fraction collected. Each point represents the mean ± S.E.M. of 3–4 different experiments, each run in triplicate (3 superfusion chambers for each condition). Error bars are absent when the S.E.M. was smaller than the symbol used in the graph. b Log concentration-response curves for BzATP in evoking [3H]D-ASP efflux and its Mg2+ sensitivity. BzATP (0.01–3 mM) was present in the standard perfusion medium for 4 min (min 38 through min 41). To assess the Mg2+–sensitivity of the effects of BzATP, synaptosomes were perfused for 18 min (min 20 through min 37) with standard medium in which the Mg2+ concentration had been reduced from 1.2 mmol/L to 0.01 mmol/L and then with the same medium containing BzATP (min 38 through min 41). The effects of the BzATP were expressed as percentage increases (ratio of the AUC observed in the presence of BzATP to the AUC for the release observed in the absence of the agonist). Data are means ± S.E.M. of at least 3 experiments, each run in triplicate. *P < 0.05 vs basal release. c Effects of ATP and BzATP on basal [3H]D-ASP release and their antagonism by A438079. A438079 (5 μM) was added to the perfusion medium 8 min before the agonists. ATP (1 mM) or BzATP (100 μM) was present in the standard perfusion medium (with or without A438079) for 4 min (minutes 38 through 41). Results are expressed as areas under the release/time-curves (AUCs). Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal release](https://figures.cochat.ai/paper-figures/c4b18e5efca64f0dabe77345e7e063ca/p2x7-receptors-exert-a-permissive-effect-on-the-activation-of-presynaptic-ampa-figure-1.jpg)
![Fig. 2 Effects of AMPA on basal and 12 mM [K+]e-evoked [3H]D-ASP release from rat TCN synaptosomes. a Effects of AMPA and antagonism by NBQX. Synaptosomes were prepared as previously described, and perfused for 37 min with standard medium. From min 38 through min 41, perfusion was carried out with standard medium containing 100 μM AMPA or depolarizing medium plus 100 μM AMPA. When used, the antagonist NBQX (10 μM) was added to the medium 8 min before AMPA. Each point represents the mean ± S.E.M. of 3–4 different experiments, each run in triplicate. b Cyclothiazide-sensitivity. The AMPA receptor desensitization inhibitor cyclothiazide (CTZ) (10 μM) was added concomitantly with AMPA (0.1–300 μM) to the depolarizing medium. The effects of the drugs on evoked release are expressed as percentage increases over values observed in the presence of the depolarizing stimulus alone. Data are means ± SEM of 3 experiments, each run in triplicate. *P < 0.05 vs [K+]e-evoked [3H]D-ASP release](https://figures.cochat.ai/paper-figures/12c61e1055b74b029ccf95704b7d15a4/p2x7-receptors-exert-a-permissive-effect-on-the-activation-of-presynaptic-ampa-figure-2.jpg)
![Fig. 3 Effects of AMPA and ATP (or BzATP) alone or in combination on basal [3H]D-ASP release: a Effects of AMPA and ATP alone or in combination on basal [3H]D-ASP release and their antagonism by NBQX. After 38 min of perfusion with standard medium, synaptosomes were exposed for 4 min to standard medium containing AMPA (100 μM), ATP (1 mM), or both drugs together. When used, the antagonist NBQX (10 μM) was added to the medium 8 min before the agonists. All results are expressed as areas under the release/time curves (AUCs). Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal release. **P < 0.01 vs basal release. b Effects of BzATP and AMPA alone or in combination and their antagonism by A438079 and by NBQX. The effects of BzATP were tested at two concentrations (10 and 100 μM), each in the presence or absence of AMPA (100 μM). Exposure times to agonists and antagonists (A438079 and NBQX) are those described in panel A. Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal release. **P < 0.01 vs basal release](https://figures.cochat.ai/paper-figures/b82a384218054c57b591342edf9bff90/p2x7-receptors-exert-a-permissive-effect-on-the-activation-of-presynaptic-ampa-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ATP can increase the expression of amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) by stimulating P2X 7 R and increasing the amplitude of miniature excitatory postsynaptic currents. 196”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [196]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular and Molecular Mechanisms of Pain
Basbaum, A. I., Bautista, D. M., Scherrer, G., & Julius, D. (2009) · Cell · doi:10.1016/j.cell.2009.09.028 · Cited by 4,344 · cited 1×
“It contains second-order neurons whose nerve endings project into higher nerve centers and excitatory and inhibitory interneurons [15].”
BackgroundNeuronal plasticity: Increasing the gain in pain
Woolf, C. J., & Salter, M. W. (2000) · Science · doi:10.1126/science.288.5472.1765 · Cited by 3,781 · cited 1×
“intracytoplasmic receptors to the membrane and in part by phosphorylation-mediated increase in receptor/ion channel function [38, 39].”
BackgroundCentral sensitization and LTP: do pain and memory share similar mechanisms?
Ji, R.-R., Kohno, T., Moore, K. A., & Woolf, C. J. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.09.017 · Cited by 1,463 · cited 1×
“intracytoplasmic receptors to the membrane and in part by phosphorylation-mediated increase in receptor/ion channel function [38, 39].”
BackgroundPurine and pyrimidine receptors
Burnstock, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6497-0 · Cited by 929
P2X receptors as cell-surface ATP sensors in health and disease
Khakh, B. S., & Alan North, R. (2006) · Nature · doi:10.1038/nature04886 · Cited by 856 · cited 1×
“Furthermore, P2X7 receptors, that are ligand-gated ion channels that conduct Na and Ca [28], can trigger the exocytotic release of Glu, a features which is also compatible with their putative role in determining the susceptibility to the spreading depolarization.”
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 789 · cited 1×
“P2X7-knockout mice display a lack of hypersensitivity to mechanical and thermal stimuli [5], and P2X7-specific antagonists have consistently been found to produce protective effects in animal models of inflammatory and neuropathic pain [6].”
BackgroundPharmacology of Cloned P2X Receptors
North, R. A., & Surprenant, A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.563 · Cited by 701 · cited 5×
“Since such concentrations are likely to have multiple actions, our subsequent experiments were performed with BzATP, which is more potent than ATP in activating the P2X7 receptor subtype [34].”
BackgroundMethodInfluentialKhakh, B. S., Burnstock, G., Kennedy, C., King, B. F., North, R. A., Séguéla, P., Voigt, M., & Humphrey, P. P. A. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01482-0 · Cited by 667
Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons
Passafaro, M., Piëch, V., & Sheng, M. (2001) · Nature Neuroscience · doi:10.1038/nn0901-917 · Cited by 655 · cited 1×
“AMPA receptors containing the GluA2 subunits are continuously inserted into synapses, whereas synaptic activity is required for insertion of those containing the GluA1 subunit [52, 53].”
BackgroundSpreading Depression Triggers Headache by Activating Neuronal Panx1 Channels
Karatas, H., Erdener, S. E., Gursoy-Ozdemir, Y., Lule, S., Eren-Koçak, E., Sen, Z. D., & Dalkara, T. (2013) · Science · doi:10.1126/science.1231897 · Cited by 513 · cited 1×
“Notably, migraine aura-related cortical spreading depression is associated with the opening of PANX1 channels, which are tightly coupled to P2X7 receptors, suggesting that a massive release of ATP occurs during a migraine attack [26, 27].”
Background
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
Involvement of P2X7 receptors in chronic pain disorders
Ren, W., & Illés, P. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09796-5 · Cited by 68
“Nerve endings isolated from the rat trigeminal caudal nucleus were loaded with tritiated aspartic acid in order to model the endogenous glutamate secretion [53].”
MethodAstrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS
Zhao, Y., Tang, Y., & Illés, P. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.641570 · Cited by 65
“More convincing evidence for the existence of presynaptic P2X7Rs was supplied, when pinched-off nerve terminals (synaptosomes) were prepared from various parts of the rodent and human brain (mouse cerebellum, Sanchez-Nogueiro et al., 2005; rat caudal brainstem, D’Amico et al., 2010; Curro et al., 2020; neocortex of ep…”
Esparza, T. J., Su, S., Francescutti, C. M., Rodionova, E., Kim, J. H., & Brody, D. L. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00462-z · Cited by 51
“Brain P2X7 receptor activation has been implicated in the pathophysiology of traumatic brain injury, posttraumatic headache, ischemic and hemorrhagic stroke, multiple sclerosis, neurodegenerative disorders, depression, and other conditions [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58].”
BackgroundPresynaptic AMPA Receptors in Health and Disease
Zanetti, L., Regoni, M., Ratti, E., Valtorta, F., & Sassone, J. (2021) · Cells · doi:10.3390/cells10092260 · Cited by 33
“The authors isolated nerve endings from the rat TCN, loaded them with [3H]D-aspartate and measured radioactivity to assess [3H]D-aspartate release under different experimental conditions.”
Influential
Metadata
- Authors
- Currò, D., Navarra, P., Samengo, I., & Martire, M.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Martire, Maria
- Venue
- The Journal of Headache and Pain
- Published
- 2020-07-02
- Volume
- 21
- Issue
- 1
- Pages
- 83-83
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- PMC
- PMC7330953
- OpenAlex
- W3039993279
- Cited by
- 18
- References
- 62
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 3
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- The Journal of Headache and Pain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by)
- Funders
- Fondi di Ateneo D1 2019 (R4124500867)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- P2X7 receptor, ATP release, A438079, NBQX, central sensitization, chronic pain, migraine, purinergic signaling, synaptic transmission
- MeSH terms
- Animals, Male, Nerve Endings, Synaptic Transmission, Synaptosomes, Trigeminal Caudal Nucleus, Receptors, Presynaptic, Receptors, AMPA, Excitatory Amino Acid Antagonists, Rats, Receptors, Purinergic P2X7, Purinergic P2X Receptor Agonists, Purinergic P2X Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals. https://app.cochat.ai/papers/10.1186/s10194-020-01153-y
- The paper
- Currò, D., Navarra, P., Samengo, I., & Martire, M. (2020). P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-020-01153-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.